Literature DB >> 23911286

Identification of PHRF1 as a tumor suppressor that promotes the TGF-β cytostatic program through selective release of TGIF-driven PML inactivation.

Asma Ettahar1, Olivier Ferrigno, Ming-Zhu Zhang, Mutsuko Ohnishi, Nathalie Ferrand, Céline Prunier, Laurence Levy, Marie-Françoise Bourgeade, Ivan Bieche, Damian G Romero, Frédéric Colland, Azeddine Atfi.   

Abstract

The homeodomain protein TGIF (TG-interacting factor) restricts TGF-β/Smad cytostatic signaling by interfering with the nucleocytoplasmic transit of the tumor suppressor cPML. Here, we identify PHRF1 as a ubiquitin ligase that enforces TGIF decay by driving its ubiquitination at lysine 130. In so doing, PHRF1 ensures redistribution of cPML into the cytoplasm, where it associates with SARA and coordinates activation of Smad2 by the TGF-β receptor. The PHRF1 gene resides within the tumor suppressor locus 11p15.5, which displays frequent loss in a wide variety of malignancies, including breast cancer. Remarkably, we found that the PHRF1 gene is deleted or silenced in a high proportion of human breast cancer samples and cancer cell lines. Reconstitution of PHRF1 into deficient cells impeded their propensity to form tumors in vivo, most likely because of the reemergence of TGF-β responsiveness. These findings unveil a paradigm behind inactivation of the cPML tumor suppressor network in human malignancies.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23911286     DOI: 10.1016/j.celrep.2013.07.009

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  16 in total

1.  TGIF governs a feed-forward network that empowers Wnt signaling to drive mammary tumorigenesis.

Authors:  Ming-Zhu Zhang; Olivier Ferrigno; Zhe Wang; Mutsuko Ohnishi; Céline Prunier; Laurence Levy; Mohammed Razzaque; Williams C Horne; Damian Romero; Guri Tzivion; Frédéric Colland; Roland Baron; Azeddine Atfi
Journal:  Cancer Cell       Date:  2015-04-13       Impact factor: 31.743

2.  Disruption of the PHRF1 Tumor Suppressor Network by PML-RARα Drives Acute Promyelocytic Leukemia Pathogenesis.

Authors:  Céline Prunier; Ming-Zhu Zhang; Santosh Kumar; Laurence Levy; Olivier Ferrigno; Guri Tzivion; Azeddine Atfi
Journal:  Cell Rep       Date:  2015-02-12       Impact factor: 9.423

3.  Comparative clinical and genomic analysis of neurofibromatosis type 2-associated cranial and spinal meningiomas.

Authors:  Alexander Pemov; Ramita Dewan; Nancy F Hansen; Settara C Chandrasekharappa; Abhik Ray-Chaudhury; Kristine Jones; Wen Luo; John D Heiss; James C Mullikin; Prashant Chittiboina; Douglas R Stewart; Ashok R Asthagiri
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.379

4.  TGIF1 functions as a tumor suppressor in pancreatic ductal adenocarcinoma.

Authors:  Parash Parajuli; Purba Singh; Zhe Wang; Lianna Li; Sailaja Eragamreddi; Seval Ozkan; Olivier Ferrigno; Celine Prunier; Mohammed S Razzaque; Keli Xu; Azeddine Atfi
Journal:  EMBO J       Date:  2019-05-31       Impact factor: 11.598

5.  Single-Molecule RNA Sequencing Reveals IFNγ-Induced Differential Expression of Immune Escape Genes in Merkel Cell Polyomavirus-Positive MCC Cell Lines.

Authors:  Tatjana Sauerer; Christopher Lischer; Adrian Weich; Carola Berking; Julio Vera; Jan Dörrie
Journal:  Front Microbiol       Date:  2021-12-22       Impact factor: 5.640

6.  EP1 receptor antagonism mitigates early and late stage renal fibrosis.

Authors:  Jean-Claude Kresse; Henricus A M Mutsaers; Michael Schou Jensen; Stine Julie Tingskov; Mia Gebauer Madsen; Lene N Nejsum; Helle Praetorius; Rikke Nørregaard
Journal:  Acta Physiol (Oxf)       Date:  2022-01-30       Impact factor: 7.523

7.  PHRF1 promotes genome integrity by modulating non-homologous end-joining.

Authors:  C-F Chang; P-C Chu; P-Y Wu; M-Y Yu; J-Y Lee; M-D Tsai; M-S Chang
Journal:  Cell Death Dis       Date:  2015-04-09       Impact factor: 8.469

8.  Overexpression of PHRF1 attenuates the proliferation and tumorigenicity of non-small cell lung cancer cells.

Authors:  Yadong Wang; Haiyu Wang; Teng Pan; Li Li; Jiangmin Li; Haiyan Yang
Journal:  Oncotarget       Date:  2016-09-27

9.  Homeodomain Protein Transforming Growth Factor Beta-Induced Factor 2 Like, X-Linked Function in Colon Adenocarcinoma Cells

Authors:  Abolfazl Akbari; Shahram Agah; Mansour Heidari; Gholam Reza Mobini; Ebrahim Faghihloo; Arash Sarveazad; Alireza Mirzaei
Journal:  Asian Pac J Cancer Prev       Date:  2017-08-27

10.  Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.

Authors:  Gerald Goh; Ramona Schmid; Kelly Guiver; Wichit Arpornwirat; Imjai Chitapanarux; Vinod Ganju; Seock-Ah Im; Sung-Bae Kim; Arunee Dechaphunkul; Jedzada Maneechavakajorn; Neil Spector; Thomas Yau; Mehdi Afrit; Slim Ben Ahmed; Stephen R Johnston; Neil Gibson; Martina Uttenreuther-Fischer; Javier Herrero; Charles Swanton
Journal:  PLoS Med       Date:  2016-12-06       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.